Publications

  1. Serrano GE, Walker JE, Tremblay C, Piras IS, Huentelman MJ, Belden CM, Goldfarb D, Shprecher D, Atri A, Adler CH, Shill HA, Driver-Dunckley E, Mehta SH, Caselli R, Woodruff BK, Haarer CF, Ruhlen T, Torres M, Nguyen S, Schmitt D, Rapscak SZ, Bime C, Peters JL, Alevritis E, Arce RA, Glass MJ, Vargas D, Sue LI, Intorcia AJ, Nelson CM, Oliver J, Russell A, Suszczewicz KE, Borja CI, Cline MP, Hemmingsen SJ, Qiji S, Hobgood HM, Mizgerd JP, Sahoo MK, Zhang H, Solis D, Montine TJ, Berry GJ, Reiman EM, Roltgen K, Boyd SD, Pinsky BA, Zehnder JL, Talbot P, Desforges M, DeTure M, Dickson DW, Beach TG. SARS-CoV-2 Brain Regional Detection, Histopathology, Gene Expression, and Immunomodulatory Changes in Decedents with COVID-19. J Neuropathol Exp Neurol. 2022 Jul 11 Epub 2022 July 11
    View PubMed
  2. Tremblay C, Serrano GE, Intorcia AJ, Mariner MR, Sue LI, Arce RA, Atri A, Adler CH, Belden CM, Shill HA, Driver-Dunckley E, Mehta SH, Beach TG. Olfactory Bulb Amyloid-beta Correlates With Brain Thal Amyloid Phase and Severity of Cognitive Impairment. J Neuropathol Exp Neurol. 2022 Jun 25 Epub 2022 June 25
    View PubMed
  3. Callister MN, Stonnington CB, Cuc A, Alcott SB, Driver-Dunckley ED, Mehta SH, Hasan S, Marks LA, Wingerchuk DM, O'Carroll CB. In Patients With Functional Movement Disorders, Is Specialized Physical Therapy Effective in Improving Motor Symptoms?: A Critically Appraised Topic. Neurologist. 2022 Jan 20; 27 (2):82-88
    View PubMed
  4. Monaghan AS, Finley JM, Mehta SH, Peterson DS. Assessing the impact of dual-task reactive step practice in people with Parkinson's disease: A feasibility study. Hum Mov Sci. 2021 Dec; 80:102876 Epub 2021 Sept 14
    View PubMed
  5. Hauser RA, Mehta SH, Kremens D, Chernick D, Formella AE. Effects of Gocovri (Amantadine) Extended-Release Capsules on Motor Aspects of Experiences of Daily Living in People with Parkinson's Disease and Dyskinesia. Neurol Ther. 2021 Dec; 10 (2):739-751 Epub 2021 May 22
    View PubMed
  6. Lea R, Benge JF, Adler CH, Beach TG, Belden CM, Zhang N, Shill HA, Driver-Dunckley E, Mehta SH, Atri A. An initial exploration of the convergent and ecological validity of the UDS 3.0 neuropsychological battery in Parkinson's Disease. J Clin Exp Neuropsychol. 2021 Nov; 43 (9):918-925 Epub 2022 Feb 09
    View PubMed
  7. Schwarzschild MA, Ascherio A, Casaceli C, Curhan GC, Fitzgerald R, Kamp C, Lungu C, Macklin EA, Marek K, Mozaffarian D, Oakes D, Rudolph A, Shoulson I, Videnovic A, Scott B, Gauger L, Aldred J, Bixby M, Ciccarello J, Gunzler SA, Henchcliffe C, Brodsky M, Keith K, Hauser RA, Goetz C, LeDoux MS, Hinson V, Kumar R, Espay AJ, Jimenez-Shahed J, Hunter C, Christine C, Daley A, Leehey M, de Marcaida JA, Friedman JH, Hung A, Bwala G, Litvan I, Simon DK, Simuni T, Poon C, Schiess MC, Chou K, Park A, Bhatti D, Peterson C, Criswell SR, Rosenthal L, Durphy J, Shill HA, Mehta SH, Ahmed A, Deik AF, Fang JY, Stover N, Zhang L, Dewey RB Jr, Gerald A, Boyd JT, Houston E, Suski V, Mosovsky S, Cloud L, Shah BB, Saint-Hilaire M, James R, Zauber SE, Reich S, Shprecher D, Pahwa R, Langhammer A, LaFaver K, LeWitt PA, Kaminski P, Goudreau J, Russell D, Houghton DJ, Laroche A, Thomas K, McGraw M, Mari Z, Serrano C, Blindauer K, Rabin M, Kurlan R, Morgan JC, Soileau M, Ainslie M, Bodis-Wollner I, Schneider RB, Waters C, Ratel AS, Beck CA, Bolger P, Callahan KF, Crotty GF, Klements D, Kostrzebski M, McMahon GM, Pothier L, Waikar SS, Lang A, Mestre T, Parkinson Study Group SURE-PD3 Investigators. Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial. JAMA. 2021 Sep 14; 326 (10):926-939
    View PubMed
  8. Sharma VD, Safarpour D, Mehta SH, Vanegas-Arroyave N, Weiss D, Cooney JW, Mari Z, Fasano A. Telemedicine and Deep brain stimulation - Current practices and recommendations. Parkinsonism Relat Disord. 2021 Aug; 89:199-205 Epub 2021 July 08
    View PubMed
  9. Adler CH, Beach TG, Zhang N, Shill HA, Driver-Dunckley E, Mehta SH, Atri A, Caviness JN, Serrano G, Shprecher DR, Sue LI, Belden CM. Clinical Diagnostic Accuracy of Early/Advanced Parkinson Disease: An Updated Clinicopathologic Study. Neurol Clin Pract. 2021 Aug; 11 (4):e414-e421
    View PubMed
  10. Shill HA, Zhang N, Driver-Dunckley E, Mehta S, Adler CH, Beach TG. Olfaction in Neuropathologically Defined Progressive Supranuclear Palsy. Mov Disord. 2021 Jul; 36 (7):1700-1704 Epub 2021 Mar 23
    View PubMed
  11. Mehta SH, Pahwa R, Tanner CM, Hauser RA, Johnson R. Effects of Gocovri (Amantadine) Extended Release Capsules on Non-Motor Symptoms in Patients with Parkinson's Disease and Dyskinesia. Neurol Ther. 2021 Jun; 10 (1):307-320 Epub 2021 Apr 17
    View PubMed
  12. Gupta HV, Beach TG, Mehta SH, Shill HA, Driver-Dunckley E, Sabbagh MN, Belden CM, Liebsack C, Dugger BN, Serrano GE, Sue LI, Siderowf A, Pontecorvo MJ, Mintun MA, Joshi AD, Adler CH. Clinicopathological Correlation: Dopamine and Amyloid PET Imaging with Neuropathology in Three Subjects Clinically Diagnosed with Alzheimer's Disease or Dementia with Lewy Bodies. J Alzheimers Dis. 2021; 80 (4):1603-1612
    View PubMed
  13. Beach TG, Adler CH, Sue LI, Shill HA, Driver-Dunckley E, Mehta SH, Intorcia AJ, Glass MJ, Walker JE, Arce R, Nelson CM, Serrano GE. Vagus Nerve and Stomach Synucleinopathy in Parkinson's Disease, Incidental Lewy Body Disease, and Normal Elderly Subjects: Evidence Against the "Body-First" Hypothesis. J Parkinsons Dis. 2021; 11 (4):1833-1843
    View PubMed
  14. Peterson DS, Barajas JS, Denney L, Mehta SH. Backward Protective Stepping During Dual-Task Scenarios in People With Parkinson's Disease: A Pilot Study. Neurorehabil Neural Repair. 2020 Aug; 34 (8):702-710 Epub 2020 July 07
    View PubMed
  15. Shprecher DR, Adler CH, Zhang N, Shill HA, Belden CM, Driver-Dunckley E, Mehta SH, Davis KJ, Sue LI, Zamrini E, Beach TG. Do Parkinson disease subject and caregiver-reported Epworth sleepiness scale reponses correlate? Clin Neurol Neurosurg. 2020 May; 192:105728 Epub 2020 Feb 06
    View PubMed
  16. Beach TG, Adler CH, Zhang N, Serrano GE, Sue LI, Driver-Dunckley E, Mehta SH, Zamrini EE, Sabbagh MN, Shill HA, Belden CM, Shprecher DR, Caselli RJ, Reiman EM, Davis KJ, Long KE, Nicholson LR, Intorcia AJ, Glass MJ, Walker JE, Callan MM, Oliver JC, Arce R, Gerkin RC. Severe hyposmia distinguishes neuropathologically confirmed dementia with Lewy bodies from Alzheimer's disease dementia. PLoS One. 2020; 15 (4):e0231720 Epub 2020 Apr 22
    View PubMed
  17. Serrano GE, Shprecher D, Callan M, Cutler B, Glass M, Zhang N, Walker J, Intorcia A, Adler CH, Shill HA, Driver-Dunckley E, Mehta SH, Belden CM, Zamrini E, Sue LI, Vargas D, Beach TG. Cardiac sympathetic denervation and synucleinopathy in Alzheimer's disease with brain Lewy body disease. Brain Commun. 2020; 2 (1):fcaa004 Epub 2020 Jan 28
    View PubMed
  18. Gupta HV, Zhang N, Driver-Dunckley E, Mehta SH, Beach TG, Adler CH. Contrast Acuity With Different Colors in Parkinson's Disease. Mov Disord Clin Pract. 2019 Nov; 6 (8):672-677 Epub 2019 Sept 06
    View PubMed
  19. Adler CH, Serrano GE, Zhang N, Hinni ML, Lott DG, Mehta SH, Sue LI, Intorcia A, Beach TG. Feasibility of repeat and bilateral submandibular gland needle biopsies in Parkinson's disease. Parkinsonism Relat Disord. 2019 Nov; 68:69-72 Epub 2019 Oct 07
    View PubMed
  20. Adler CH, Beach TG, Zhang N, Shill HA, Driver-Dunckley E, Caviness JN, Mehta SH, Sabbagh MN, Serrano GE, Sue LI, Belden CM, Powell J, Jacobson SA, Zamrini E, Shprecher D, Davis KJ, Dugger BN, Hentz JG. Unified Staging System for Lewy Body Disorders: Clinicopathologic Correlations and Comparison to Braak Staging. J Neuropathol Exp Neurol. 2019 Oct 1; 78 (10):891-899
    View PubMed
  21. Driver-Dunckley ED, Zhang N, Shill HA, Mehta SH, Belden CM, Zamrini EY, Davis K, Beach TG, Adler CH. Correlation Between the Movement Disorder Society's Unified Parkinson's Disease Rating Scale and Nonmotor Scales in Patients with Parkinson's Disease. Innov Clin Neurosci. 2019 Sep 1; 16 (9-10):27-29
    View PubMed
  22. El-Nazer R, Adler CH, Beach TG, Belden CM, Artz J, Shill HA, Driver-Dunckley E, Mehta SH, Sabbagh MN, Serrano GE, Sue LI, Zamrini E, Benge JF. Regional neuropathology distribution and verbal fluency impairments in Parkinson's disease. Parkinsonism Relat Disord. 2019 Aug; 65:73-78 Epub 2019 May 10
    View PubMed
  23. Hansen AL, Krell-Roesch J, Kirlin KA, Limback-Stokin MM, Roesler K, Velgos SN, Lyons MK, Geda YE, Mehta SH. Deep Brain Stimulation and Cognitive Outcomes Among Patients With Parkinson's Disease: A Historical Cohort Study. J Neuropsychiatry Clin Neurosci. 2019 Summer; 31 (3):196-200 Epub 2019 Feb 22
    View PubMed
  24. Parsons AM, Mehta SH, Acierno MD, Dhamija R. Teaching Video NeuroImages: MT-TL1 mutation presenting as chronic progressive external ophthalmoplegia. Neurology. 2019 Jan 22; 92 (4):e394
    View PubMed
  25. Savica R, Beach TG, Hentz JG, Sabbagh MN, Serrano GE, Sue LI, Dugger BN, Shill HA, Driver-Dunckley E, Caviness JN, Mehta SH, Jacobson SA, Belden CM, Davis KJ, Zamrini E, Shprecher DR, Adler CH. Lewy body pathology in Alzheimer's disease: A clinicopathological prospective study. Acta Neurol Scand. 2019 Jan; 139 (1):76-81 Epub 2018 Oct 07
    View PubMed
  26. Driver-Dunckley ED, Zhang N, Adler CH, Serrano GE, Sue LI, Shill HA, Mehta SH, Belden CM, Zamrini EY, Davis K, Beach TG. Brain Lewy-Type Synucleinopathy Density Is Associated with a Lower Prevalence of Atherosclerotic Cardiovascular Disease Risk Factors in Patients with Parkinson's Disease1. J Parkinsons Dis. 2019; 9 (3):543-552
    View PubMed
  27. Malek-Ahmadi M, Beach TG, Zamrini E, Adler CH, Sabbagh MN, Shill HA, Jacobson SA, Belden CM, Caselli RJ, Woodruff BK, Rapscak SZ, Ahern GL, Shi J, Caviness JN, Driver-Dunckley E, Mehta SH, Shprecher DR, Spann BM, Tariot P, Davis KJ, Long KE, Nicholson LR, Intorcia A, Glass MJ, Walker JE, Callan M, Curry J, Cutler B, Oliver J, Arce R, Walker DG, Lue LF, Serrano GE, Sue LI, Chen K, Reiman EM. Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body disease. PLoS One. 2019; 14 (6):e0217566 Epub 2019 June 25
    View PubMed
  28. Shprecher DR, Adler CH, Zhang N, Hentz JG, Serrano GE, Dugger BN, Shill HA, Savica R, Caviness JN, Sabbagh MN, Belden CM, Driver-Dunckley E, Mehta SH, Sue LI, Davis KJ, Zamrini E, Beach TG. Predicting alpha-synuclein pathology by REM sleep behavior disorder diagnosis. Parkinsonism Relat Disord. 2018 Oct; 55:92-96 Epub 2018 May 17
    View PubMed
  29. Gupta HV, Mehta SH, Zhang N, Hentz JG, Shill HA, Driver-Dunckley E, Sabbagh MN, Belden CM, Dugger BN, Beach TG, Serrano GE, Sue LI, Davis K, Adler CH. Are Clinical Certainty Ratings Helpful in the Diagnosis of Parkinson's Disease? Mov Disord Clin Pract. 2018 Mar-Apr; 5 (2):165-170 Epub 2018 Feb 22
    View PubMed
  30. DiBaise JK, Crowell MD, Driver-Dunckley E, Mehta SH, Hoffman-Snyder C, Lin T, Adler CH. Weight Loss in Parkinson's Disease: No Evidence for Role of Small Intestinal Bacterial Overgrowth. J Parkinsons Dis. 2018; 8 (4):571-581
    View PubMed
  31. Aslam S, Zhang N, Adler CH, Caviness JN, Driver-Dunckley E, Mehta SH, Sabbagh MN, Belden C, Zamrini E, Beach TG, Shill HA. Essential tremor and depression. Mov Disord Clin Pract. 2017 Nov-Dec; 4 (6):838-842 Epub 2017 July 17
    View PubMed
  32. Gerkin RC, Adler CH, Hentz JG, Shill HA, Driver-Dunckley E, Mehta SH, Sabbagh MN, Caviness JN, Dugger BN, Serrano G, Belden C, Smith BH, Sue L, Davis KJ, Zamrini E, Beach TG. Improved diagnosis of Parkinson's disease from a detailed olfactory phenotype. Ann Clin Transl Neurol. 2017 Oct; 4 (10):714-721 Epub 2017 Sept 08
    View PubMed
  33. Adler CH, Dugger BN, Hentz JG, Hinni ML, Lott DG, Driver-Dunckley E, Mehta S, Serrano G, Sue LI, Duffy A, Intorcia A, Filon J, Pullen J, Walker DG, Beach TG. Peripheral synucleinopathy in early Parkinson's disease: Submandibular gland needle biopsy findings. Mov Disord. 2017 May; 32: (5)722-723.
    View PubMed
  34. Pal GD, Ouyang B, Serrano G, Shill HA, Goetz C, Stebbins G, Metman LV, Driver-Dunckley E, Mehta SH, Caviness JN, Sabbagh MN, Adler CH, Beach TG, Arizona Study of Aging Neurodegenerative Disorders. Comparison of neuropathology in Parkinson's disease subjects with and without deep brain stimulation. Mov Disord. 2017 Feb; 32 (2):274-277 Epub 2016 Dec 02
    View PubMed
  35. de Roos P, Bloem BR, Kelley TA, Antonini A, Dodel R, Hagell P, Marras C, Martinez-Martin P, Mehta SH, Odin P, Chaudhuri KR, Weintraub D, Wilson B, Uitti RJ. A Consensus Set of Outcomes for Parkinson's Disease from the International Consortium for Health Outcomes Measurement. J Parkinsons Dis. 2017; 7 (3):533-543
    View PubMed
  36. Gupta HV, Lyons MK, Mehta SH. Teaching NeuroImages: Noninfectious cyst as an unusual complication of deep brain stimulation. Neurology. 2016 Nov 1; 87 (18):e223-e224
    View PubMed
  37. Utianski RL, Caviness JN, van Straaten EC, Beach TG, Dugger BN, Shill HA, Driver-Dunckley ED, Sabbagh MN, Mehta S, Adler CH, Hentz JG. Graph theory network function in Parkinson's disease assessed with electroencephalography. Clin Neurophysiol. 2016 May; 127: (5)2228-36.
    View PubMed
  38. Caviness JN, Utianski RL, Hentz JG, Beach TG, Dugger BN, Shill HA, Driver-Dunckley ED, Sabbagh MN, Mehta S, Adler CH. Differential spectral quantitative electroencephalography patterns between control and Parkinson's disease cohorts. Eur J Neurol. 2016 Feb; 23 (2):387-92 Epub 2015 Oct 31
    View PubMed
  39. Adler CH, Dugger BN, Hentz JG, Hinni ML, Lott DG, Driver-Dunckley E, Mehta S, Serrano G, Sue LI, Duffy A, Intorcia A, Filon J, Pullen J, Walker DG, Beach TG. Peripheral Synucleinopathy in Early Parkinson's Disease: Submandibular Gland Needle Biopsy Findings. Mov Disord. 2016 Feb; 31 (2):250-6 Epub 2016 Jan 22
    View PubMed
  40. Mehta SH, Adler CH. Advances in Biomarker Research in Parkinson's Disease. Curr Neurol Neurosci Rep. 2016 Jan; 16 (1):7
    View PubMed
  41. Gupta HV, Gervais C, Ross MA, Mehta SH. Purkinje Cell Cytoplasmic Antibody (PCA-2)-related Chorea-Dystonia Syndrome. Tremor Other Hyperkinet Mov (N Y). 2016; 6:420 Epub 2016 Sept 24
    View PubMed
  42. Silver MR, Sethi KD, Mehta SH, Nichols FT, Morgan JC. Case report of optic atrophy in Dentatorubropallidoluysian Atrophy (DRPLA). BMC Neurol. 2015 Dec 18; 15:260
    View PubMed
  43. Hentz JG, Mehta SH, Shill HA, Driver-Dunckley E, Beach TG, Adler CH. Simplified conversion method for unified Parkinson's disease rating scale motor examinations. Mov Disord. 2015 Dec; 30 (14):1967-70 Epub 2015 Nov 17
    View PubMed
  44. Mehta SH, Morgan JC, Sethi KD. Drug-induced movement disorders. Neurol Clin. 2015 Feb; 33 (1):153-74
    View PubMed
  45. Mehta SH, Sawhney IM, Yoganathan K, Trumble JP, Morgan JC, Sethi KD. Treatment of Involuntary Movements with Carbamazepine in Dystonic-Choreoathetoid Cerebral Palsy. Mov Disord Clin Pract. 2014 Apr; 1 (1):82-83 Epub 2014 Apr 10
    View PubMed
  46. Mehta SH, Switzer JA, Biddinger P, Rojiani AM. IgG4-related leptomeningitis: a reversible cause of rapidly progressive cognitive decline. Neurology. 2014 Feb 11; 82(6):540-2.
  47. Wakade CG, Mehta SH, Maeda M, et al. Axonal fasciculation and the role of polysialic acid-neural cell adhesion molecule in rat cortical neurons. J Neurosci Res. 2013 Nov; 91(11):1408-18. Epub 2013 Aug
  48. Herz NB, Mehta SH, Sethi KD, Jackson P, Hall P, Morgan JC. Nintendo Wii rehabilitation ("Wii-hab") provides benefits in Parkinson's disease. Parkinsonism Relat Disord. 2013 Nov; 19(11):1039-42. Epub 2013 Aug
  49. Mehta SH, Nichols FT 3rd, Espay AJ, Duker AP, Morgan JC, Sethi KD. Dilated Virchow-Robin spaces and parkinsonism. Mov Disord. 2013 May; 28(5):589-90. Epub 2013 Apr 10.
    View PubMed
  50. Giller C, Mehta S, Yanasak N, Jenkins P. Avoidance of electrode related MRI artifact during staged deep brain stimulator implantation. J Neurol Surg A Cent Eur Neurosurg. 2012 Sep; 73(5):320-3. Epub 2012 Jul 30.
    View PubMed
  51. Sethi KD, Mehta SH. A clinical primer on restless legs syndrome: what we know, and what we don't know. Am J Manag Care. 2012 Aug; 18(5 Suppl):S83-8.
    View PubMed
  52. Chong RK, Lee KH, Morgan J, Mehta SH, Hall P, Sethi K. Diagnostic value of the rapid assessment of postural instability in Parkinson's disease (RAPID) questionnaire. Int J Clin Pract. 2012 Jul; 66(7):718-21.
    View PubMed
  53. Chong RK, Morgan J, Mehta SH, Pawlikowska I, Hall P, Ellis AV, Ibanez-Wong AD, Miller GM, Baugh K, Sethi K. Rapid assessment of postural instability in Parkinson's disease (RAPID): a pilot study. Eur J Neurol. 2011 Feb; 18(2):260-5.
    View PubMed
  54. Morgan JC, Mehta SH, Sethi KD. Biomarkers in Parkinson's disease. Curr Neurol Neurosci Rep. 2010 Nov; 10(6):423-30.
    View PubMed
  55. Segev DL, Muzaale AD, Caffo BS, Mehta SH, Singer AL, Taranto SE, McBride MA, Montgomery RA. Perioperative mortality and long-term survival following live kidney donation. JAMA. 2010 Mar 10; 303 (10):959-66
    View PubMed
  56. Mehta SH, Morgan JC, Sethi KD. Paraneoplastic movement disorders. Curr Neurol Neurosci Rep. 2009 Jul; 9(4):285-91.
    View PubMed
  57. Mehta SH, Prakash R, Prisant LM, Isales CM, Morgan JC, Williams H, Sethi KD. Diagnosis of pheochromocytoma in the setting of Parkinson disease. Nat Rev Neurol. 2009 Jun; 5(6):343-7.
    View PubMed
  58. Mehta SH, Morgan JC, Sethi KD. Paroxysmal dyskinesias. Curr Treat Options Neurol. 2009 May; 11(3):170-8.
    View PubMed
  59. Mehta SH, Morgan JC, Sethi KD. Neuroimaging and transcranial ultrasonography in Parkinson's disease. Curr Neurol Neurosci Rep. 2008 Jul; 8(4):297-303.
    View PubMed
  60. Mehta SH, Morgan JC, Sethi KD. Sleep disorders associated with Parkinson's disease: role of dopamine, epidemiology, and clinical scales of assessment. CNS Spectr. 2008 Mar; 13(3 Suppl 4):6-11.
    View PubMed
  61. Marrufo M, Politsky J, Mehta S, Morgan JC, Sethi KD. Paroxysmal Kinesigenic Segmental Myoclonus due to a spinal cord glioma. Mov Disord. 2007 Sep 15; 22(12):1801-3.
    View PubMed
  62. Mehta SH, Adams RJ. Treatment and prevention of stroke in children with sickle cell disease. Curr Treat Options Neurol. 2006 Nov; 8(6):503-12.
    View PubMed
  63. Slovut DP, Mehta SH, Dorrance AM, Brosius FC, Watts SW, Webb RC. Increased vascular sensitivity and connexin43 expression after sympathetic denervation. Cardiovasc Res. 2004 May 1; 62(2):388-96.
    View PubMed
  64. Mehta SH, Webb RC, Ergul A, Tawfik A, Dorrance AM. Neuroprotection by tempol in a model of iron-induced oxidative stress in acute ischemic stroke. Am J Physiol Regul Integr Comp Physiol. 2004 Feb; 286(2):R283-8. Epub 2003 Oct 30.
    View PubMed
  65. Mehta SH, Dhandapani KM, De Sevilla LM, Webb RC, Mahesh VB, Brann DW. Tamoxifen, a selective estrogen receptor modulator, reduces ischemic damage caused by middle cerebral artery occlusion in the ovariectomized female rat. Neuroendocrinology. 2003 Jan; 77(1):44-50.
    View PubMed
  66. Komalavilas P, Mehta S, Wingard CJ, Dransfield DT, Bhalla J, Woodrum JE, Molinaro JR, Brophy CM. PI3-kinase/Akt modulates vascular smooth muscle tone via cAMP signaling pathways. J Appl Physiol (1985). 2001 Oct; 91(4):1819-27.
    View PubMed